Other Heart Failure Measures



ACE-I/ARB at Discharge (HF)

What are we measuring and why?

MGH tracks the percentage of eligible adult heart failure patients who were given prescriptions at discharge for either of two classes of drugs: an ACE inhibitor (ACE-I) or an angiotensin receptor blocker (ARB). National guidelines recommend both of these drugs, which have been proven to improve the heart’s ability to pump blood to the body.  Studies have determined that heart failure patients who take one of these medicines have fewer symptoms, are physically better, and have a lower risk of a return to the hospital.

How are we doing and how do we compare to best practice?

This data is no longer collected by the Joint Commission, nor is it publically reported. MGH continues to focus on performance in this category, and strive to match or exceed the national average. Our performance for the last reporting period, January 2014 to December 2014 was 97%. The national average for all Joint Commission accredited hospitals was 98%.

Click to see MGH’s performance on this measure by patients’ race.

  • Current Scores
  • Scores Over Time
  • Higher values are better
98% 100% 97%

MGH Source: Hospital administrative data and chart review.
Comparison Group Source: CMS/TJC National Hospital Quality Measures.

N.B. Data for this measure is no longer being collected, nor is it publically reported.

MGH: Jan 14-Dec 14
TJC: Jan 14-Dec 14

94 94 95 95 97 97 94 97 97 97 97 97 98 98 97 98 100 100 100 100 100 100 100 100

MGH Source: Hospital administrative data and chart review.
Comparison Group Source: CMS/TJC National Hospital Quality Measures.

N.B. Data for this measure is no longer being collected, nor is it publically reported.



What are we doing to improve?

MGH has used a number of approaches to improve adherence with this guideline, including clinician to clinician education and reminders. In addition, we have reorganized our process of reminders and now employ an automated electronic reminder system, so that before a heart failure patient is discharged, the physician must either prescribe an ACE-I or ARB, or indicate that it is not appropriate. These types of interventions are used selectively to improve the reliability with which the right care is delivered and should see improved outcomes going forward.

What can you do?

If you or a family member are hospitalized with heart failure, you can play a role in ensuring the quality of care by being aware of the availability and use of ACE-I or ARBs and asking your physician if you will be receiving a prescription for one of them at hospital discharge. If the physician suggests that such drugs are not appropriate, ask why they are not recommended so that you understand why these drugs may not be right for you.

 

« Previous Page